{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:48:28Z","timestamp":1770518908229,"version":"3.49.0"},"reference-count":55,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,2,7]]},"DOI":"10.1248\/bpb.b25-00607","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:08:39Z","timestamp":1770415719000},"page":"254-266","source":"Crossref","is-referenced-by-count":0,"title":["Regulation of ER-Resident Transcription Factor NFE2L1 in HEK293 Cells"],"prefix":"10.1248","volume":"49","author":[{"given":"Maiko","family":"Yasui","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, 1\u20131 Yanagido, Gifu 501\u20131193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Nagae","sequence":"additional","affiliation":[{"name":"Graduate School of Natural Science and Technology, Gifu University, 1\u20131 Yanagido, Gifu 501\u20131193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Murase","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, 1\u20131 Yanagido, Gifu 501\u20131193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozue","family":"Uchio-Yamada","sequence":"additional","affiliation":[{"name":"Laboratory of Animal Models for Human Diseases, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka 567\u20130085, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Kandeel","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadayuki","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Faculty of Agriculture, Saga University, 1 Honjo-machi, Saga 840\u20138502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Oh-hashi","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, 1\u20131 Yanagido, Gifu 501\u20131193, Japan"},{"name":"Graduate School of Natural Science and Technology, Gifu University, 1\u20131 Yanagido, Gifu 501\u20131193, Japan"},{"name":"United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1\u20131 Yanagido, Gifu 501\u20131193, Japan"},{"name":"Center for One Medicine Innovative Translational Research (COMIT), Gifu University, 1\u20131 Yanagido, Gifu 501\u20131193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ellgaard L, Helenius A. Quality control in the endoplasmic reticulum. <i>Nat. Rev. Mol. Cell Biol.<\/i>, <b>4<\/b>, 181\u2013191 (2003).","DOI":"10.1038\/nrm1052"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Vembar SS, Brodsky JL. One step at a time: endoplasmic reticulum-associated degradation. <i>Nat. Rev. Mol. Cell Biol.<\/i>, <b>9<\/b>, 944\u2013957 (2008).","DOI":"10.1038\/nrm2546"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ninagawa S, George G, Mori K. Mechanisms of productive folding and endoplasmic reticulum-associated degradation of glycoproteins and non-glycoproteins. <i>Biochim. Biophys. Acta, Gen. Subj.<\/i>, <b>1865<\/b>, 129812 (2021).","DOI":"10.1016\/j.bbagen.2020.129812"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hoseki J, Ushioda R, Nagata K. Mechanism and components of endoplasmic reticulum-associated degradation. <i>J. Biochem.<\/i>, <b>147<\/b>, 19\u201325 (2010).","DOI":"10.1093\/jb\/mvp194"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Christianson JC, Ye Y. Cleaning up in the endoplasmic reticulum: ubiquitin in charge. <i>Nat. Struct. Mol. Biol.<\/i>, <b>21<\/b>, 325\u2013335 (2014).","DOI":"10.1038\/nsmb.2793"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Fang S, Ferrone M, Yang C, Jensen JP, Tiwari S, Weissman AM. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>98<\/b>, 14422\u201314427 (2001).","DOI":"10.1073\/pnas.251401598"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hosokawa N, Wada I, Hasegawa K, Yorihuzi T, Tremblay LO, Herscovics A, Nagata K. A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. <i>EMBO Rep.<\/i>, <b>2<\/b>, 415\u2013422 (2001).","DOI":"10.1093\/embo-reports\/kve084"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Gnann A, Riordan JR, Wolf DH. Cystic fibrosis transmembrane conductance regulator degradation depends on the lectins Htm1p\/EDEM and the Cdc48 protein complex in yeast. <i>Mol. Biol. Cell<\/i>, <b>15<\/b>, 4125\u20134135 (2004).","DOI":"10.1091\/mbc.e04-01-0024"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ninagawa S, Okada T, Takeda S, Mori K. SEL1L is required for endoplasmic reticulum-associated degradation of misfolded luminal proteins but not transmembrane proteins in chicken DT40 cell line. <i>Cell Struct. Funct.<\/i>, <b>36<\/b>, 187\u2013195 (2011).","DOI":"10.1247\/csf.11018"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Jo Y, Sguigna PV, DeBose-Boyd RA. Membrane-associated ubiquitin ligase complex containing gp78 mediates sterol-accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. <i>J. Biol. Chem.<\/i>, <b>286<\/b>, 15022\u201315031 (2011).","DOI":"10.1074\/jbc.M110.211326"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Horimoto S, Ninagawa S, Okada T, Koba H, Sugimoto T, Kamiya Y, Kato K, Takeda S, Mori K. The unfolded protein response transducer ATF6 represents a novel transmembrane-type endoplasmic reticulum-associated degradation substrate requiring both mannose trimming and SEL1L protein. <i>J. Biol. Chem.<\/i>, <b>288<\/b>, 31517\u201331527 (2013).","DOI":"10.1074\/jbc.M113.476010"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sun S, Shi G, Sha H, <i>et al<\/i>. IRE1\u03b1 is an endogenous substrate of endoplasmic-reticulum-associated degradation. <i>Nat. Cell Biol.<\/i>, <b>17<\/b>, 1546\u20131555 (2015).","DOI":"10.1038\/ncb3266"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Murase R, Yamamoto A, Hirata Y, Oh-hashi K. Expression analysis and functional characterization of thioredoxin domain-containing protein 11. <i>Mol. Biol. Rep.<\/i>, <b>49<\/b>, 10541\u201310556 (2022).","DOI":"10.1007\/s11033-022-07932-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ruvkun G, Lehrbach N. Regulation and functions of the ER-associated Nrf1 transcription factor. <i>Cold Spring Harb. Perspect. Biol.<\/i>, <b>15<\/b>, a041266 (2023).","DOI":"10.1101\/cshperspect.a041266"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Oh-hashi K, Yamamoto A, Murase R, Hirata Y. Comparative analysis of CREB3 and CREB3L2 protein expression in HEK293 cells. <i>Int. J. Mol. Sci.<\/i>, <b>22<\/b>, 2767 (2021).","DOI":"10.3390\/ijms22052767"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Murase R, Kato G, Oh-hashi K. Regulation of the ER-resident mannosidase EDEM2 in HEK293 cells. <i>BPB Reports<\/i>, <b>6<\/b>, 193\u2013199 (2023).","DOI":"10.1248\/bpbreports.6.6_193"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Asada R, Kanemoto S, Kondo S, Saito A, Imaizumi K. The signalling from endoplasmic reticulum-resident bZIP transcription factors involved in diverse cellular physiology. <i>J. Biochem.<\/i>, <b>149<\/b>, 507\u2013518 (2011).","DOI":"10.1093\/jb\/mvr041"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) George G, Ninagawa S, Yagi H, Saito T, Ishikawa T, Sakuma T, Yamamoto T, Imami K, Ishihama Y, Kato K, Okada T, Mori K. EDEM2 stably disulfide-bonded to TXNDC11 catalyzes the first mannose trimming step in mammalian glycoprotein ERAD. <i>eLife<\/i>, <b>9<\/b>, e53455 (2020).","DOI":"10.7554\/eLife.53455"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. <i>Mol. Cell. Biol.<\/i>, <b>15<\/b>, 4184\u20134193 (1995).","DOI":"10.1128\/MCB.15.8.4184"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kim HM, Han JW, Chan JY. Nuclear Factor Erythroid-2 Like 1 (NFE2L1): Structure, function and regulation. <i>Gene<\/i>, <b>584<\/b>, 17\u201325 (2016).","DOI":"10.1016\/j.gene.2016.03.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Radhakrishnan SK, Lee CS, Young P, Beskow A, Chan JY, Deshaies RJ. Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. <i>Mol. Cell<\/i>, <b>38<\/b>, 17\u201328 (2010).","DOI":"10.1016\/j.molcel.2010.02.029"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Radhakrishnan SK, den Besten W, Deshaies RJ. p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition. <i>eLife<\/i>, <b>3<\/b>, e01856 (2014).","DOI":"10.7554\/eLife.01856"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Steffen J, Seeger M, Koch A, Kr\u00fcger E. Proteasomal degradation is transcriptionally controlled by TCF11 <i>via<\/i> an ERAD-dependent feedback loop. <i>Mol. Cell<\/i>, <b>40<\/b>, 147\u2013158 (2010).","DOI":"10.1016\/j.molcel.2010.09.012"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Lehrbach NJ, Breen PC, Ruvkun G. Protein sequence editing of SKN-1A\/Nrf1 by peptide: N-glycanase controls proteasome gene expression. <i>Cell<\/i>, <b>177<\/b>, 737\u2013750.e15 (2019).","DOI":"10.1016\/j.cell.2019.03.035"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Tachida Y, Hirayama H, Suzuki T. Amino acid editing of NFE2L1 by PNGase causes abnormal mobility on SDS-PAGE. <i>Biochim. Biophys. Acta, Gen. Subj.<\/i>, <b>1867<\/b>, 130494 (2023).","DOI":"10.1016\/j.bbagen.2023.130494"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Koizumi S, Irie T, Hirayama S, Sakurai Y, Yashiroda H, Naguro I, Ichijo H, Hamazaki J, Murata S. The aspartyl protease DDI2 activates Nrf1 to compensate for proteasome dysfunction. <i>eLife<\/i>, <b>5<\/b>, e18357 (2016).","DOI":"10.7554\/eLife.18357"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Zhang T, Xu Y, Liu Y, Ye Y. gp78 functions downstream of Hrd1 to promote degradation of misfolded proteins of the endoplasmic reticulum. <i>Mol. Biol. Cell.<\/i>, <b>26<\/b>, 4438\u20134450 (2015).","DOI":"10.1091\/mbc.E15-06-0354"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Yang Q, Chen X, Zhang Y, Hu S, Hu F, Huang Y, Ma T, Hu H, Tian H, Tian S, Ji YX, She ZG, Zhang P, Zhang XJ, Hu Y, Yang H, Yuan Y, Li H. The E3 ubiquitin ligase ring finger protein 5 ameliorates NASH through ubiquitin-mediated degradation of 3-hydroxy-3-methylglutaryl CoA reductase degradation protein 1. <i>Hepatology<\/i>, <b>74<\/b>, 3018\u20133036 (2021).","DOI":"10.1002\/hep.32061"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Harada K, Kato M, Nakamura N. USP19-Mediated deubiquitination facilitates the stabilization of HRD1 ubiquitin ligase. <i>Int. J. Mol. Sci.<\/i>, <b>17<\/b>, 1829 (2016).","DOI":"10.3390\/ijms17111829"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-guided human genome engineering <i>via<\/i> Cas9. <i>Science<\/i>, <b>339<\/b>, 823\u2013826 (2013).","DOI":"10.1126\/science.1232033"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Tresse E, Salomons FA, Vesa J, Bott LC, Kimonis V, Yao TP, Dantuma NP, Taylor JP. VCP\/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. <i>Autophagy<\/i>, <b>6<\/b>, 217\u2013227 (2010).","DOI":"10.4161\/auto.6.2.11014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Oh-hashi K, Kunieda R, Hirata Y, Kiuchi K. Biosynthesis and secretion of mouse cysteine-rich with EGF-like domains 2. <i>FEBS Lett.<\/i>, <b>585<\/b>, 2481\u20132487 (2011).","DOI":"10.1016\/j.febslet.2011.06.029"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kondo S, Hino SI, Saito A, Kanemoto S, Kawasaki N, Asada R, Izumi S, Iwamoto H, Oki M, Miyagi H, Kaneko M, Nomura Y, Urano F, Imaizumi K. Activation of OASIS family, ER stress transducers, is dependent on its stabilization. <i>Cell Death Differ.<\/i>, <b>19<\/b>, 1939\u20131949 (2012).","DOI":"10.1038\/cdd.2012.77"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Hu S, Xiang Y, Qiu L, Wang M, Zhang Y. Activation of the membrane-bound Nrf1 transcription factor by USP19, a ubiquitin-specific protease C-terminally anchored in the endoplasmic reticulum. <i>Biochim. Biophys. Acta Mol. Cell Res.<\/i>, <b>1869<\/b>, 119299 (2022).","DOI":"10.1016\/j.bbamcr.2022.119299"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Zhong X, Shen Y, Ballar P, Apostolou A, Agami R, Fang S. AAA ATPase p97\/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. <i>J. Biol. Chem.<\/i>, <b>279<\/b>, 45676\u201345684 (2004).","DOI":"10.1074\/jbc.M409034200"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) DeLaBarre B, Christianson JC, Kopito RR, Brunger AT. Central pore residues mediate the p97\/VCP activity required for ERAD. <i>Mol. Cell<\/i>, <b>22<\/b>, 451\u2013462 (2006).","DOI":"10.1016\/j.molcel.2006.03.036"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Pontifex CS, Zaman M, Fanganiello RD, Shutt TE, Pfeffer G. 2005 Valosin-Containing Protein (VCP): a review of its diverse molecular functions and clinical phenotypes. <i>Int. J. Mol. Sci.<\/i>, <b>25<\/b>, 5633 (2024).","DOI":"10.3390\/ijms25115633"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Hanson PI, Whiteheart SW. AAA+ proteins: have engine, will work. <i>Nat. Rev. Mol. Cell Biol.<\/i>, <b>6<\/b>, 519\u2013529 (2005).","DOI":"10.1038\/nrm1684"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Bastola P, Neums L, Schoenen FJ, Chien J. VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal. <i>Mol. Oncol.<\/i>, <b>10<\/b>, 1559\u20131574 (2016).","DOI":"10.1016\/j.molonc.2016.09.005"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Anderson DJ, Le Moigne R, Djakovic S, <i>et al<\/i>. Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis. <i>Cancer Cell<\/i>, <b>28<\/b>, 653\u2013665 (2015).","DOI":"10.1016\/j.ccell.2015.10.002"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Phan JM, Creekmore BC, Nguyen AT, Bershadskaya DD, Darwich NF, Mann CN, Lee EB. VCP activator reverses nuclear proteostasis defects and enhances TDP-43 aggregate clearance in multisystem proteinopathy models. <i>J. Clin. Invest.<\/i>, <b>134<\/b>, e169039 (2024).","DOI":"10.1172\/JCI169039"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Carrera Espinoza MJ, Tucker SK, Sureshkumar S, Gamble ME, Hakim NL, Orrantia S, Espitia CM, Cruickshank-Taylor AB, Wang W, Kelly KR, Carew JS, Nawrocki ST. Harnessing p97\/VCP:a transformative AAA+ ATPase target for next-generation cancer therapeutics. <i>Cancers<\/i>, <b>17<\/b>, 2945 (2025).","DOI":"10.3390\/cancers17182945"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Chavarria C, Zaffalon L, Ribeiro ST, Op M, Quadroni M, Iatrou MS, Chapuis C, Martinon F. ER-trafficking triggers NRF1 ubiquitination to promote its proteolytic activation. <i>iScience<\/i>, <b>26<\/b>, 107777 (2023).","DOI":"10.1016\/j.isci.2023.107777"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Shmueli A, Tsai YC, Yang M, Braun MA, Weissman AM. Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: cross-talk between E3s in the endoplasmic reticulum. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>390<\/b>, 758\u2013762 (2009).","DOI":"10.1016\/j.bbrc.2009.10.045"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Krshnan L, van de Weijer ML, Carvalho P. Endoplasmic reticulum-associated protein degradation. <i>Cold Spring Harb. Perspect. Biol.<\/i>, <b>14<\/b>, a041247 (2022).","DOI":"10.1101\/cshperspect.a041247"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Kimonis VE, Fulchiero E, Vesa J, Watts G. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. <i>Biochim. Biophys. Acta<\/i>, <b>1782<\/b>, 744\u2013748 (2008).","DOI":"10.1016\/j.bbadis.2008.09.003"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Bastola P, Wang F, Schaich MA, Gan T, Freudenthal BD, Chou TF, Chien J. Specific mutations in the D1-D2 linker region of VCP\/p97 enhance ATPase activity and confer resistance to VCP inhibitors. <i>Cell Death Discov.<\/i>, <b>3<\/b>, 17065 (2017).","DOI":"10.1038\/cddiscovery.2017.65"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Wang F, Li S, Rosencrans WM, Cheng KW, Stott GM, Mroczkowski B, Chou TF. Sulforaphane is synergistic with CB-5083 and inhibits colony formation of CB-5083-resistant HCT116 cells. <i>ChemMedChem<\/i>, <b>17<\/b>, e202200030 (2022).","DOI":"10.1002\/cmdc.202200030"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Shaw CE. Capturing VCP: another molecular piece in the ALS jigsaw puzzle. <i>Neuron<\/i>, <b>68<\/b>, 812\u2013814 (2010).","DOI":"10.1016\/j.neuron.2010.11.040"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Tomlin FM, Gerling-Driessen UIM, Liu YC, Flynn RA, Vangala JR, Lentz CS, Clauder-Muenster S, Jakob P, Mueller WF, Ordo\u00f1ez-Rueda D, Paulsen M, Matsui N, Foley D, Rafalko A, Suzuki T, Bogyo M, Steinmetz LM, Radhakrishnan SK, Bertozzi CR. Inhibition of NGLY1 inactivates the transcription factor Nrf1 and potentiates proteasome inhibitor cytotoxicity. <i>ACS Cent. Sci.<\/i>, <b>3<\/b>, 1143\u20131155 (2017).","DOI":"10.1021\/acscentsci.7b00224"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Fassmannov\u00e1 D, Sedl\u00e1k F, Sedl\u00e1\u010dek J, \u0160pi\u010dka I, Grantz \u0160a\u0161kov\u00e1 K. Nelfinavir inhibits the TCF11\/Nrf1-mediated proteasome recovery pathway in multiple myeloma. <i>Cancers<\/i>, <b>12<\/b>, 1065 (2020).","DOI":"10.3390\/cancers12051065"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Zhang Y, Lucocq JM, Hayes JD. The Nrf1 CNC\/bZIP protein is a nuclear envelope-bound transcription factor that is activated by <i>t<\/i>-butyl hydroquinone but not by endoplasmic reticulum stressors. <i>Biochem. J.<\/i>, <b>418<\/b>, 293\u2013310 (2009).","DOI":"10.1042\/BJ20081575"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Yoshida Y, Takahashi T, Ishii N, Matsuo I, Takahashi S, Inoue H, Endo A, Tsuchiya H, Okada M, Ando C, Suzuki T, Dohmae N, Saeki Y, Tanaka K, Suzuki T. Sugar-mediated non-canonical ubiquitination impairs Nrf1\/NFE2L1 activation. <i>Mol. Cell<\/i>, <b>84<\/b>, 3115\u20133127.e11 (2024).","DOI":"10.1016\/j.molcel.2024.07.013"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Liang JR, Lingeman E, Luong T, Ahmed S, Muhar M, Nguyen T, Olzmann JA, Corn JE. A genome-wide ER-phagy screen highlights key roles of mitochondrial metabolism and ER-resident UFMylation. <i>Cell<\/i>, <b>180<\/b>, 1160\u20131177.e20 (2020).","DOI":"10.1016\/j.cell.2020.02.017"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Chino H, Mizushima N. ER-phagy: quality control and turnover of endoplasmic reticulum. <i>Trends Cell Biol.<\/i>, <b>30<\/b>, 384\u2013398 (2020).","DOI":"10.1016\/j.tcb.2020.02.001"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/2\/49_b25-00607\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:31:51Z","timestamp":1770435111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/2\/49_b25-00607\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00607","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"article-number":"b25-00607"}}